Tuohy K, Ba D, Bhanja D, Leslie D, Liu G, Mansouri A
Front Surg. 2023; 10:1001741.
PMID: 36816005
PMC: 9935584.
DOI: 10.3389/fsurg.2023.1001741.
Yamamoto A, Sanjuan A, Pope R, Jones O, Hope T, Prejawa S
Front Hum Neurosci. 2022; 16:803163.
PMID: 35652007
PMC: 9148966.
DOI: 10.3389/fnhum.2022.803163.
Muhsen B, Aljariri A, Elayyan M, Hirbawi H, Masri M
CNS Oncol. 2022; :CNS81.
PMID: 35382555
PMC: 8988253.
DOI: 10.2217/cns-2021-0014.
Greuter L, Guzman R, Soleman J
Children (Basel). 2021; 8(11).
PMID: 34828788
PMC: 8624473.
DOI: 10.3390/children8111075.
Collins K, Pollack I
Cancers (Basel). 2020; 12(5).
PMID: 32375301
PMC: 7281318.
DOI: 10.3390/cancers12051152.
Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis.
Xia L, Fang C, Chen G, Sun C
BMC Cancer. 2018; 18(1):48.
PMID: 29306321
PMC: 5756328.
DOI: 10.1186/s12885-017-3909-x.
The Challenges of Management of High-grade Gliomas in Nigeria.
Ndubuisi C, Mezue W, Nzegwu M, Okwunodulu O, Ejembi G, Ohaegbulam S
J Neurosci Rural Pract. 2017; 8(3):407-411.
PMID: 28694621
PMC: 5488562.
DOI: 10.4103/jnrp.jnrp_18_17.
Biopsy versus resection for the management of low-grade gliomas.
Jiang B, Chaichana K, Veeravagu A, Chang S, Black K, Patil C
Cochrane Database Syst Rev. 2017; 4:CD009319.
PMID: 28447767
PMC: 6478300.
DOI: 10.1002/14651858.CD009319.pub3.
Management strategies for neoplastic and vascular brain lesions presenting during pregnancy: A series of 29 patients.
Pereira C, Lynch J
Surg Neurol Int. 2017; 8:27.
PMID: 28303207
PMC: 5339909.
DOI: 10.4103/2152-7806.200575.
Clinical considerations and surgical approaches for low-grade gliomas in deep hemispheric locations: insular lesions.
Hinojosa J, Gil-Robles S, Pascual B
Childs Nerv Syst. 2016; 32(10):1875-93.
PMID: 27659830
DOI: 10.1007/s00381-016-3183-2.
Advances in the Surgical Management of Low-Grade Glioma.
Hollon T, Hervey-Jumper S, Sagher O, Orringer D
Semin Radiat Oncol. 2015; 25(3):181-8.
PMID: 26050588
PMC: 4460567.
DOI: 10.1016/j.semradonc.2015.02.007.
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
Reuss D, Mamatjan Y, Schrimpf D, Capper D, Hovestadt V, Kratz A
Acta Neuropathol. 2015; 129(6):867-73.
PMID: 25962792
PMC: 4500039.
DOI: 10.1007/s00401-015-1438-8.
Pediatric low-grade gliomas: how modern biology reshapes the clinical field.
Bergthold G, Bandopadhayay P, Bi W, Ramkissoon L, Stiles C, Segal R
Biochim Biophys Acta. 2014; 1845(2):294-307.
PMID: 24589977
PMC: 4082403.
DOI: 10.1016/j.bbcan.2014.02.004.
Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study.
Krieg S, Schnurbus L, Shiban E, Droese D, Obermueller T, Buchmann N
BMC Cancer. 2013; 13:51.
PMID: 23374675
PMC: 3583679.
DOI: 10.1186/1471-2407-13-51.
Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.
Hummel T, Chow L, Fouladi M, Franz D
Paediatr Drugs. 2013; 15(1):29-42.
PMID: 23329387
DOI: 10.1007/s40272-012-0002-4.
A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).
Stokland T, Liu J, Ironside J, Ellison D, Taylor R, Robinson K
Neuro Oncol. 2010; 12(12):1257-68.
PMID: 20861086
PMC: 3018938.
DOI: 10.1093/neuonc/noq092.
Early or delayed radiosurgery for WHO grade II astrocytomas.
Park K, Kano H, Kondziolka D, Niranjan A, Flickinger J, Lunsford L
J Neurooncol. 2010; 103(3):523-32.
PMID: 20848299
DOI: 10.1007/s11060-010-0409-0.
Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article.
Chaichana K, Halthore A, Parker S, Olivi A, Weingart J, Brem H
J Neurosurg. 2010; 114(3):604-12.
PMID: 20524825
PMC: 3725949.
DOI: 10.3171/2010.4.JNS091340.
Pediatric low-grade gliomas.
Sievert A, Fisher M
J Child Neurol. 2009; 24(11):1397-408.
PMID: 19841428
PMC: 2917804.
DOI: 10.1177/0883073809342005.
Pediatric brain tumors: current treatment strategies and future therapeutic approaches.
Mueller S, Chang S
Neurotherapeutics. 2009; 6(3):570-86.
PMID: 19560746
PMC: 5084192.
DOI: 10.1016/j.nurt.2009.04.006.